Reduced fibrin clot permeability on admission and elevated E-selectin at 3 months as novel risk factors of residual pulmonary vascular obstruction in patients with acute pulmonary embolism.

Stepien, Konrad; Zabczyk, Michal; Kopytek, Magdalena; Natorska, Joanna; Zalewski, Jaroslaw; Undas, Anetta

Stepien, Konrad; Zabczyk, Michal; Kopytek, Magdalena; Natorska, Joanna; Zalewski, Jaroslaw; Undas, Anetta.

Afiliação

Stepien K; Department of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.
Zabczyk M; Department of Coronary Artery Disease and Heart Failure, John Paul II Hospital, Kraków, Poland.
Kopytek M; Department of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.
Natorska J; Krakow Centre for Medical Research and Technologies, John Paul II Hospital, Kraków, Poland.
Zalewski J; Department of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.
Undas A; Krakow Centre for Medical Research and Technologies, John Paul II Hospital, Kraków, Poland.

J Thromb Thrombolysis ; 57(2): 248-259, 2024 Feb.

Article em En | MEDLINE | ID: mdl-37932588

Assuntos

Embolia Pulmonar; Trombose; Doenças Vasculares; Humanos; Selectina E; Embolia Pulmonar/diagnóstico; Trombose/complicações; Fatores de Risco; Fibrinólise; Fibrina/metabolismo; Tempo de Lise do Coágulo de Fibrina; Anticoagulantes; Permeabilidade

Palavras-chave

E-selectin; Fibrin clot; Pulmonary embolism; Residual pulmonary vascular obstruction; Thrombin generation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Trombose / Doenças Vasculares Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google